Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

GLP-1 Medicines Linked to Nutritional Deficiencies in Children

Mayur Tembhare
  1. Nearly one in six children (16.8%) taking GLP-1 medicines developed a nutritional deficiency within a year.

  2. Vitamin D deficiency was the most common problem, affecting 12.4% of children.

  3. Only 5% of patients received nutritional counseling within 30 days of GLP-1 treatment.

  4. Liraglutide (Victoza and Saxenda) was the most commonly prescribed GLP-1 medication.

GLP-1 Medicines Linked to Nutritional Deficiencies in Children

Topic: Health

A new study found that nearly one in six children taking GLP-1 medicines for weight loss or diabetes developed a nutritional deficiency. The most common problem was vitamin D deficiency, affecting 12.4% of children within a year. Researchers say attention to nutrition is crucial during this period.

Children taking GLP-1 medications for weight loss, prediabetes, or type 2 diabetes may face an important nutritional concern.

A new study published in Childhood Obesity found that nearly one in six young patients (16.8%) were diagnosed with a nutritional deficiency during the first year after starting treatment. Vitamin D deficiency was the most frequently identified problem, affecting 12.4% of children within one year of beginning GLP-1 therapy.

The researchers analyzed national administrative claims data collected from 2017 through 2022 and found that only 5% of patients received nutritional counseling within 30 days of GLP-1 treatment and less than 25% received nutritional counseling within 6 months. Among the children studied, liraglutide (Victoza and Saxenda) was by far the most commonly prescribed GLP-1 medication, accounting for 78.6% of prescriptions.

The researchers call for earlier nutritional support to prevent harm to children treated with GLP-1s during a pivotal period in their lives.

Why It Matters

This study is important because it highlights the need for attention to nutrition when prescribing GLP-1 medicines to children. As India struggles with rising rates of childhood obesity and diabetes, this research can inform healthcare providers about the importance of proactive nutritional management.

Key Facts

  • Nearly one in six children (16.8%) taking GLP-1 medicines developed a nutritional deficiency within a year.
  • Vitamin D deficiency was the most common problem, affecting 12.4% of children.
  • Only 5% of patients received nutritional counseling within 30 days of GLP-1 treatment.
  • Liraglutide (Victoza and Saxenda) was the most commonly prescribed GLP-1 medication.
  • The study analyzed data from over 2,000 children aged 10 to 17.

Key Terms

GLP-1
A type of medicine that helps regulate blood sugar levels and appetite.
Nutritional deficiency
When the body does not get enough essential nutrients, leading to health problems.
Vitamin D deficiency
When the body does not have enough vitamin D, which is crucial for bone growth and development.

Implications

This study is important because it highlights the need for attention to nutrition when prescribing GLP-1 medicines to children. As India struggles with rising rates of childhood obesity and diabetes, this research can inform healthcare providers about the importance of proactive nutritional management.

Source: https://www.sciencedaily.com/releases/2026/09/260923035926.htm

Journal reference:

  1. Kirk W. Kerr, Andrew T. Chang, Suela Sulo, John T. Stutts, Thadchaigeni Panchalingam, Justin R. Ryder. Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists. Childhood Obesity, 2026; DOI: 10.1177/21532176261486979

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.